Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Anavex Life Sciences stock

Learn how to easily invest in Anavex Life Sciences stock.

Anavex Life Sciences is a biotechnology business based in the US. Anavex Life Sciences shares (AVXL) are listed on the NASDAQ and all prices are listed in US Dollars. Anavex Life Sciences employs 38 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy Anavex Life Sciences stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – AVXL. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for low fees

Finder Award

SoFi Invest

  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 in stock when you fund a new account within 30 days

Promoted for social trading

Finder Award


  • Easy to use platform with $0 stock trading & no annual fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100

Promoted for active trading


  • $0 commissions on stocks and ETFs
  • $0 closing commissions on stock and ETF options
  • Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+

Anavex Life Sciences stock price (NASDAQ: AVXL)

Use our graph to track the performance of AVXL stocks over time.

Anavex Life Sciences shares at a glance

Information last updated 2023-09-24.
Latest market close$6.80
52-week range$6.75 - $15.24
50-day moving average $8.06
200-day moving average $8.87
Wall St. target price$47.75
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.64

Buy Anavex Life Sciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Name Product Ratings Available asset types Minimum deposit Signup bonus
SoFi Invest
Finder Rating: 4.6 / 5: ★★★★★

Finder Award
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
Get up to $1,000 in stock
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Rating: 4.2 / 5: ★★★★★

Finder Award
Stocks, Options, ETFs, Cryptocurrency
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Finder Rating: 4.1 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures
Get $100 - $2,000
when you you open and fund an account with $5,000 to $100,000+
Highly commended for Best Derivatives Trading Platform award.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
2.5% fee applies to all alternative asset transactions.
Finder Rating: 4.2 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4.9% interest on uninvested cash in your account with Robinhood Gold.
Finder Rating: 4 / 5: ★★★★★
Stocks, ETFs
Wealthfront builds a free financial plan for the life you want and automate your investments at a low cost.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Anavex Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Anavex Life Sciences price performance over time

Historical closes compared with the close of $6.8 from 2023-09-26

1 week (2023-09-20) -6.08%
1 month (2023-08-25) -15.42%
3 months (2023-06-27) -15.84%
6 months (2023-03-27) -20.09%
1 year (2022-09-27) -26.49%
2 years (2021-09-23) N/A
3 years (2020-09-25) 75.71%
5 years (2018-09-27) 134.48%

Anavex Life Sciences financials

Gross profit TTM $0
Return on assets TTM -21.75%
Return on equity TTM -34.72%
Profit margin 0%
Book value $1.80
Market Capitalization $564.6 million

TTM: trailing 12 months

Anavex Life Sciences share dividends

We're not expecting Anavex Life Sciences to pay a dividend over the next 12 months.

Have Anavex Life Sciences's shares ever split?

Anavex Life Sciences's shares were split on a 1:4 basis on 6 October 2015. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Anavex Life Sciences shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Anavex Life Sciences shares which in turn could have impacted Anavex Life Sciences's share price.

Anavex Life Sciences share price volatility

Over the last 12 months, Anavex Life Sciences's shares have ranged in value from as little as $6.7499 up to $15.24. A popular way to gauge a stock's volatility is its "beta".

AVXL.US volatility(beta: 0.68)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Anavex Life Sciences's is 0.6836. This would suggest that Anavex Life Sciences's shares are less volatile than average (for this exchange).

Anavex Life Sciences overview

Anavex Life Sciences Corp. , a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinical clinical trials to treat epilepsy, infantile spasms, Fragile X syndrome, Angelman syndrome, multiple sclerosis, and tuberous sclerosis complex. The company's drug candidate also comprises ANAVEX 3-71, which is in Phase I clinical trial for the treatment of frontotemporal dementia; and preclinical clinical trials for the treatment of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Its preclinical drug candidates include ANAVEX 1-41, a sigma-1 receptor agonist for the treatment of depression, stroke, Parkinson's, and Alzheimer's diseases; ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the potential treatment of neuropathic and visceral pain; and ANAVEX 1037 to treat prostate and pancreatic cancer. The company was incorporated in 2004 and is headquartered in New York, New York. .

Frequently asked questions

What percentage of Anavex Life Sciences is owned by insiders or institutions?
Currently 3.194% of Anavex Life Sciences shares are held by insiders and 33.901% by institutions.
How many people work for Anavex Life Sciences?
Latest data suggests 38 work at Anavex Life Sciences.
When does the fiscal year end for Anavex Life Sciences?
Anavex Life Sciences's fiscal year ends in September.
Where is Anavex Life Sciences based?
Anavex Life Sciences's address is: 630 5th Avenue, New York, NY, United States, 10111
What is Anavex Life Sciences's ISIN number?
Anavex Life Sciences's international securities identification number is: US0327973006
What is Anavex Life Sciences's CUSIP number?
Anavex Life Sciences's Committee on Uniform Securities Identification Procedures number is: 032797102

More guides on Finder

Ask an Expert provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site